Successful management of fulminant myocarditis with left ventricular assist device: Report of a severe case

Annals of Thoracic and Cardiovascular Surgery

Volumn 16, Issue 1, 2010, Pages 48-51

  Unosawa, Satoshi ^a   Hata, Mitsumasa ^a   Sezai, Akira ^a   Niino, Tetsuya ^a   Yoshitake, Isamu ^a   Shimura, Kazuma ^a   Takamori, Tatsuya ^a   Minami, Kazutomo ^a  

^a NIHON UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Fulminant myocarditis; Left ventricular assist device; Percutaneous cardiopulmonary support

Indexed keywords

AGED; AORTA BALLOON; ARTICLE; CARDIOGENIC SHOCK; CASE REPORT; CONVALESCENCE; HEART ASSIST DEVICE; HOSPITALIZATION; HUMAN; MALE; MULTIPLE ORGAN FAILURE; MYOCARDITIS; PATHOPHYSIOLOGY; RADIOGRAPHY; TIME; TREATMENT OUTCOME;

AGED; HEART-ASSIST DEVICES; HUMANS; INTRA-AORTIC BALLOON PUMPING; MALE; MULTIPLE ORGAN FAILURE; MYOCARDITIS; RECOVERY OF FUNCTION; SEVERITY OF ILLNESS INDEX; SHOCK, CARDIOGENIC; TIME FACTORS; TREATMENT OUTCOME;

EID: 77649132455     PISSN: 13411098     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Lieberman EB, Hutchins GM, Herskowitz A, Rose NR, Baughman KL. Clinicopathologic description of myocarditis. J Am Coll Cardiol 1991; 18: 1617-26.
2. Aretz HT, Billingham ME, Edwards WD, Factor SM, Fallon JT, et al. Myocarditis. A histopathologic definition and classification. Am J Cardiovasc Pathol 1987; 1: 3-14.
3. Takeda Y, Yasuda S, Miyazaki S, Daikoku S, Nakatani S, et al. High-dose immunoglobulin G therapy for fulminant myocarditis. Jpn Circ J 1998; 62: 871-2.
4. Shioji K, Matsuura Y, Iwase T, Kitaguchi S, Nakamura H, et al. Successful immunoglobulin treatment for fulminant myocarditis and serial analysis of serum thioredoxin: a case report. Circ J 2002; 66: 977-80.
5. Abe S, Okura Y, Hoyano M, Kazama R, Watanabe S, et al. Plasma concentrations of cytokines and neurohumoral factors in a case of fulminant myocarditis successfully treated with intravenous immunoglobulin and percutaneous cardiopulmonary support. Circ J 2004; 68: 1223-6.
6. Chen YS, Yu HY, Huang SC, Chiu KM, Lin TY, et al. Experience and result of extracorporeal membrane oxygenation in treating fulminant myocarditis with shock: what mechanical support should be considered first? J Heart Lung Transplant 2005; 24: 81-7.
7. Tokunaga S, Morita S, Masuda M, Tomita Y, Nishida T, et al. How to cope with the pitfalls of extracorporeal membrane oxygenation support: case report of a girl with fulminant myocarditis. J Artif Organs 2007; 10: 115-7.
8. Aoyama N, Izumi T, Hiramori K, Isobe M, Kawana M, et al. National survey of fulminant myocarditis in Japan: therapeutic guidelines and long-term prognosis of using percutaneous cardiopulmonary support for fulminant myocarditis (special report from a scientific committee). Circ J 2002; 66: 133-44.
9. Peek GJ, Killer HM, Sosnowski MA, Firmin RK. Modular extracorporeal life support for multiorgan failure patients. Liver 2002; 22 (Suppl 2): 69-71.
10. Reinhartz O, Farrar DJ, Hershon JH, Avery GJ Jr, Haeusslein EA, et al. Importance of preoperative liver function as a predictor of survival in patients supported with Thoratec ventricular assist devices as a bridge to transplantation. J Thorac Cardiovasc Surg 1998; 116: 633-40.
11. Hata M, Shiono M, Orime Y, Yagi SY, Yamamoto T, et al. Strategy of circulatory support with percutaneous cardiopulmonary support. Artif Organs 2000; 24: 636-9.
12. Gojo S, Kyo S, Sato H, Nishimura M, Asakura T, et al. Successful LVAS and RVAS-ECMO support in a patient with fulminant myocarditis who failed to recover from ventricular fibrillation with PCPS and IABP. J Thorac Cardiovasc Surg 2003; 126: 885-6.
13. Rockman HA, Adamson RM, Dembitsky WP, Bonar JW, Jaski BE. Acute fulminant myocarditis: long-term follow-up after circulatory support with left ventricular assist device. Am Heart J 1991; 121 (3 Pt 1): 922-6.
14. Maybaum S, Stockwell P, Naka Y, Catanese K, Flannery M, et al. Assessment of myocardial recovery in a patient with acute myocarditis supported with a left ventricular assist device: a case report. J Heart Lung Transplant 2003; 22: 202-9.
15. Leprince P, Combes A, Bonnet N, Ouattara A, Luyt CE, et al. Circulatory support for fulminant myocarditis: consideration for implantation, weaning and explantation. Eur J Cardiothorac Surg 2003; 24: 399-403.
16. Holman WL, Bourge RC, Kirklin JK. Case report: circulatory support for seventy days with resolution of acute heart failure. J Thorac Cardiovasc Surg 1991; 102: 932-4.
17. Reiss N, El-Banayosy A, Arusoglu L, Blanz U, Bairaktaris A, et al. Acute fulminant myocarditis in children and adolescents: the role of mechanical circulatory assist. ASAIO J 2006; 52: 211-4.